Growth Metrics

Cerus (CERS) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.19%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 64.73%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.89%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 29.56%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Cerus 549.42 Mn 469.73 Mn 27.89 Mn 52.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 52.77%
Dec 31, 2025 45.49%
Sep 30, 2025 86.71%
Jun 30, 2025 12.03%
Mar 31, 2025 14.35%
Dec 31, 2024 -27.41%
Sep 30, 2024 38.21%
Jun 30, 2024 27.83%
Mar 31, 2024 17.82%
Dec 31, 2023 65.89%
Sep 30, 2023 19.83%
Jun 30, 2023 3.58%
Mar 31, 2023 1.70%
Dec 31, 2022 7.00%
Sep 30, 2022 22.02%
Jun 30, 2022 21.81%
Mar 31, 2022 13.21%
Dec 31, 2021 2.93%
Sep 30, 2021 4.30%
Jun 30, 2021 -4.97%
Mar 31, 2021 -7.93%
Dec 31, 2020 -16.88%
Sep 30, 2020 -1.76%
Jun 30, 2020 4.52%
Mar 31, 2020 3.98%
Dec 31, 2019 -8.46%
Sep 30, 2019 -7.72%
Jun 30, 2019 1.12%
Mar 31, 2019 -3.68%
Dec 31, 2018 62.02%
Sep 30, 2018 3.27%
Jun 30, 2018 5.96%
Mar 31, 2018 -13.65%
Dec 31, 2017 -35.37%
Sep 30, 2017 -7.64%
Jun 30, 2017 -31.06%
Mar 31, 2017 -335.61%
Dec 31, 2016 -33.73%
Sep 30, 2016 11.16%
Jun 30, 2016 -39.28%
Mar 31, 2016 -18.04%
Dec 31, 2015 -121.21%
Sep 30, 2015 -53.53%
Jun 30, 2015 -41.98%
Mar 31, 2015 -2.31%
Dec 31, 2014 64.16%
Sep 30, 2014 -89.09%
Jun 30, 2014 -5.79%
Mar 31, 2014 64.66%
Dec 31, 2013 -45.45%
Sep 30, 2013 -76.49%
Jun 30, 2013 -19.85%